methacrylamide has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Biswas, S; Bobde, Y; Ghosh, B; Patel, T; Paul, M | 2 |
| Chen, D; Li, T; Ma, R; Tang, J; Wu, J; Wu, Y; Zhang, J; Zhang, W | 1 |
3 other study(ies) available for methacrylamide and Breast Neoplasms
| Article | Year |
|---|---|
PEGylated N-(2 hydroxypropyl) methacrylamide polymeric micelles as nanocarriers for the delivery of doxorubicin in breast cancer.
Topics: Acrylamides; Breast Neoplasms; Doxorubicin; Drug Carriers; Female; Humans; Micelles; Polyethylene Glycols; Polymers | 2021 |
Polymeric micelles of a copolymer composed of all-trans retinoic acid, methoxy-poly(ethylene glycol), and b-poly(N-(2 hydroxypropyl) methacrylamide) as a doxorubicin-delivery platform and for combination chemotherapy in breast cancer.
Topics: Acrylamides; Breast Neoplasms; Doxorubicin; Drug Carriers; Drug Therapy, Combination; Female; Humans; Hydrogen-Ion Concentration; Micelles; Polyethylene Glycols; Tretinoin | 2021 |
Multivalent methionine-functionalized biocompatible block copolymers for targeted small interfering RNA delivery and subsequent reversal effect on adriamycin resistance in human breast cancer cell line MCF-7/ADR.
Topics: Acrylamides; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Methionine; Polymers; RNA, Small Interfering; Transfection | 2017 |